Search Results - "Stratz, T"

Refine Results
  1. 1

    The classification of fibromyalgia syndrome by Müller, W, Schneider, E M, Stratz, T

    Published in Rheumatology international (01-09-2007)
    “…As has been shown by a number of working groups, primary fibromyalgia syndrome does not represent a single clinical entity. It is possible to distinguish…”
    Get full text
    Journal Article
  2. 2

    Local treatment of tendinopathies and myofascial pain syndromes with the 5-HT3 receptor antagonist tropisetron by Müller, W, Stratz, T

    “…The use of local tropisetron injections improved the treatment of tendinopathies considerably, with the effect being comparable to the topical application of…”
    Get more information
    Journal Article
  3. 3

    Efficacy and tolerability of intravenous tropisetron in the treatment of fibromyalgia by Späth, M, Stratz, T, Neeck, G, Kötter, I, Hammel, B, Amberger, CC, Haus, U, Färber, L, Pongratz, D, Müller, W

    Published in Scandinavian journal of rheumatology (01-07-2004)
    “…Objective: To determine the efficacy of a serotonin receptor (5-HT3) antagonist in the treatment of fibromyalgia (FM) in a prospective, randomized,…”
    Get full text
    Journal Article
  4. 4

    Expression of 5-HT3A receptors in cells of the immune system by Fiebich, BL, Akundi, RS, Seidel, M, Geyer, V, Haus, U, Müller, W, Stratz, T, Candelario-Jalil, E

    Published in Scandinavian journal of rheumatology (01-01-2004)
    “…There is evidence from both human and animal research that 5-hydroxytryptamine3 (5-HT3) receptor antagonists, particularly tropisetron, exert analgesic and…”
    Get full text
    Journal Article
  5. 5

    Treatment of chronic low back pain with tropisetron by Stratz, T, Müller, W

    Published in Scandinavian journal of rheumatology (01-01-2004)
    “…Background: Various pathophysiological processes can lead to chronic back pain, which necessitates a differentiated therapeutic approach. In addition, psychic…”
    Get full text
    Journal Article
  6. 6

    The T102C Polymorphism of the 5-HT2A-Receptor Gene in Fibromyalgia by Bondy, Brigitta, Spaeth, Michael, Offenbaecher, Martin, Glatzeder, Karin, Stratz, Thomas, Schwarz, Markus, de Jonge, Sylvia, Krüger, Marc, Engel, Rolf R., Färber, Lothar, Pongratz, Dieter E., Ackenheil, Manfred

    Published in Neurobiology of disease (01-10-1999)
    “…Based on a possible involvement of serotonergic dysfunction in the pathophysiology of fibromyalgia (FM) and on preliminary reports of a possible genetically…”
    Get full text
    Journal Article
  7. 7

    Antiinflammatory effects of 5-HT3 receptor antagonists in lipopolysaccharide-stimulated primary human monocytes by Fiebich, BL, Akundi, RS, Lieb, K, Candelario-Jalil, E, Gmeiner, D, Haus, U, Müller, W, Stratz, T, Muñoz, E

    Published in Scandinavian journal of rheumatology (01-01-2004)
    “…There is evidence from both human and animal research that 5-hydroxytryptamine (5-HT)3 receptor antagonists, particularly tropisetron, exert analgesic and…”
    Get full text
    Journal Article
  8. 8

    Treatment of systemic sclerosis with the 5-HT3 receptor antagonist tropisetron by Stratz, T, Müller, W

    Published in Scandinavian journal of rheumatology (01-01-2004)
    “…Background: There is no known disease-modifying therapy for progressive systemic sclerosis. Objectives: It was shown that a patient with secondary fibromyalgia…”
    Get full text
    Journal Article
  9. 9

    The use of 5-HT3 receptor antagonists in various rheumatic diseases - a clue to the mechanism of action of these agents in fibromyalgia? by Müller, T. Stratz, W.

    “…In a pilot study, the action of the 5-HT3 receptor antagonist, tropisetron, on different types of local rheumatic pain and inflammatory effects was studied…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Intra-articular treatment of arthritides and activated osteoarthritis with the 5-HT3 receptor antagonist tropisetron. A double-blind study compared with methylprednisolone by Samborski, W, Stratz, T, Mackiewicz, S, Müller, W

    Published in Scandinavian journal of rheumatology (01-01-2004)
    “…Background: Since the good effect of intra-articular injections of the 5-HT3 receptor antagonist tropisetron in patients with arthritides and activated…”
    Get full text
    Journal Article
  12. 12
  13. 13

    Influence of tropisetron on the serum substance P levels in fibromyalgia patients by Stratz, T, Fiebich, B, Haus, U, Müller, W

    Published in Scandinavian journal of rheumatology (01-01-2004)
    “…Background: Substance P is found at an elevated level in the cerebrospinal fluid of fibromyalgia (FM) patients. Treatment with tropisetron leads in a subgroup…”
    Get full text
    Journal Article
  14. 14

    Subgroups of fibromyalgia by Müller, W, Schneider, M, Joos, T, Hsu, H Y, Stratz, T

    Published in Schmerz (Berlin, Germany) (01-10-2007)
    “…As has been shown by a number of working groups, primary fibromyalgia syndrome does not represent a single clinical entity. It is possible to distinguish…”
    Get full text
    Journal Article
  15. 15

    Local treatment of tendinopathies: a comparison between tropisetron and depot corticosteroids combined with local anesthetics by Stratz, Th, Färber, L., Müller, W.

    “…Objective : To determine whether local injection of the 5-HT3-receptor antagonist, tropisetron, reduces pain in tendinopathies to the same degree as a local…”
    Get full text
    Journal Article
  16. 16

    Treatment of fibromyalgia with tropisetron - dose and efficacy correlations by Späth, M, Stratz, T, Färber, L, Haus, U, Pongratz, D

    Published in Scandinavian journal of rheumatology (01-01-2004)
    “…Previous studies evaluating the efficacy and tolerance of tropisetron for the treatment of fibromyalgia (FM) used the drug either intravenously or orally, and…”
    Get full text
    Journal Article
  17. 17
  18. 18
  19. 19

    Immunomodulatory function of the 5-HT3 receptor antagonist tropisetron by Schneider, EM, Ma, X, Stratz, T, Müller, W, Lorenz, I, Seeling, WD

    Published in Scandinavian journal of rheumatology (01-01-2004)
    “…Objective: To characterize the immune modulatory effects of 5-HT3 receptor antagonist treatment in patients with fibromyalgia, autoimmune disorders, and…”
    Get full text
    Journal Article
  20. 20

    Do predictors exist for the therapeutic effect of 5-HT3 receptor antagonists in fibromyalgia? by Müller, T. Stratz, W

    “…From the findings outlined below, there are no reliable predictors of the therapeutic effect of the 5-HT3-receptor antagonists in fibromyalgia. Neither…”
    Get full text
    Journal Article